Loading...
Market
Which major pharma company will partner with Stanford for cancer treatment by November 2025?
2
Resolution / Starting Odds
Pfizer • 25%
Merck • 25%
Roche • 25%
Other • 25%
Press releases from Stanford Medicine or pharmaceutical companies
Story
Stanford Scientists Develop Novel Method to Induce Cancer Cell Self-Destruction
Nov 4, 2024, 12:03 PM
Scientists have discovered a novel method to induce self-destruction in cancer cells. Stanford researchers at Stanford Medicine have developed a technique that involves gluing two proteins together, which flips the normal action of a lymphoma protein from preventing cell death to triggering it. This advancement is part of broader efforts in genomics, where RNA molecules are designed to specifically target genes and pathways in cancer cells. Additionally, a new study by Professor Shachar Idit's team has shown that blocking 'molecular bridges' created by cancerous tumors can restore immune attacks and slow the progression of cancer.
View original story
Similar markets
Yes • 50%
No • 50%
Pfizer • 25%
Johnson & Johnson • 25%
Novartis • 25%
Other • 25%
Pfizer • 25%
Merck • 25%
Roche • 25%
Other • 25%
Yes • 50%
No • 50%
Pfizer • 25%
Merck • 25%
Roche • 25%
Other • 25%
Pfizer • 25%
Merck • 25%
Roche • 25%
Other • 25%
Pfizer • 25%
Roche • 25%
Novartis • 25%
Other • 25%
Pfizer • 25%
Moderna • 25%
Johnson & Johnson • 25%
Other • 25%
Yes • 50%
No • 50%
Roche • 25%
Novartis • 25%
Pfizer • 25%
Other • 25%
Pfizer • 25%
Roche • 25%
Novartis • 25%
Other • 25%
Pfizer • 25%
Roche • 25%
Novartis • 25%
Other • 25%